Colchicine and Heart Disease: Reading the Negative Trials Honestly

I want to walk you through one of the more interesting stories in cardiology right now, because it is not a story about a drug that failed. It is a story about what happens when a genuinely good hypothesis meets a genuinely large tr...

Frank's Sign: Does It Mean You Have Heart Disease

In 1973, an American pulmonologist named Sanders T. Frank published a brief report noting something peculiar about his patients with coronary artery disease. Many of them had a diagonal crease running across the earlobe, extending from the tragus to...

Statins, Cholesterol, And Your Brain

Your brain does not need circulating cholesterol. In fact, cholesterol circulating in your blood stream inside of lipoproteins can not get into your brain. Lipid lowering medications affect circulating cholesterol, not brain cholesterol. It's important to unders...

Intestinal Absorption of Cholesterol

Having an overall understanding of lipid and lipoprotein metabolism is important to understanding how we arrive at cholesterol in our arteries and develop atherosclerosis.

The first step is cholesterol or fatty acids arriving inside your intestinal lumen. This ...

North Karelia Finland 84% Reduction In Death Rates

In a beautiful example of how dietary and lifestyle interventions work, the country of Finland was able to reduce cardiovascular mortality by 84% in North Karelia by making a few simple dietary and lifestyle changes.

The year was 1972. North Karel...

Your Morning Coffee and Your Heart: What the American Heart Association Actually Found

Caffeine is the most widely consumed drug on the planet, and most people drinking it have no idea what it does to their cardiovascular system. The American Heart Association just released a landmark scientific st...

Four Types of Prevention and the Power of Lowering LDL

The old model of preventing heart disease had two categories. Modern cardiology has four, and knowing where you fall could change the course of your life.

Cardiovascular disease remains the leading cause of death worldwide, claiming nearly 18 ...

New Oral PCSK9 Breakthrough Enlicitide

A new oral PCSK9 inhibitor called enlicitide decanoate just produced results in a major randomized trial that rival injectable therapies, and the cardiovascular world needs to pay attention. High levels of low-density lipoprotein cholesterol (LDL-C), the “bad ...

Best Congestive Heart Failure Treatment: What the Evidence Shows

Congestive heart failure used to have an 80% five-year mortality rate. This means that in 5 years, 80% of those diagnosed with CHF would be dead. That is no longer the case. Modern medications and therapeutics have been able to add 9 ...

Ozempic Cuts Heart Attacks and Strokes by 20 Percent In Non Diabetics

I have been a huge proponent of GLP1 medications since they first hit the market in 2005. I also run a cardiometabolic, obesity, and weight loss clinic and jumped on the modern GLP1 medications early in 2019. 

People think that ...